Moving towards a vaccine

David M. Holtzman
Additional contact information
David M. Holtzman: Washington University, 660 South Euclid Avenue, St Louis, Missouri 63110, USA. holtzman@neuro.wustl.edu

Nature, 2008, vol. 454, issue 7203, 419-420

Abstract: An agent that clears disease-associated amyloid aggregates from the brains of patients with Alzheimer's disease does not alleviate disease progression. Yet this disappointing news should not rule out such potential therapies.

Date: 2008
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/454418a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:454:y:2008:i:7203:d:10.1038_454418a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/454418a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().